350 related articles for article (PubMed ID: 15501003)
21. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
Vilhelmsen T; Eliasen H; Schaefer T
Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation.
Nepal PR; Han HK; Choi HK
Int J Pharm; 2010 Jan; 383(1-2):147-53. PubMed ID: 19781608
[TBL] [Abstract][Full Text] [Related]
23. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
Newa M; Bhandari KH; Li DX; Kwon TH; Kim JA; Yoo BK; Woo JS; Lyoo WS; Yong CS; Choi HG
Int J Pharm; 2007 Oct; 343(1-2):228-37. PubMed ID: 17597315
[TBL] [Abstract][Full Text] [Related]
26. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
27. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
Sun Y; Rui Y; Wenliang Z; Tang X
Int J Pharm; 2008 Jul; 359(1-2):144-9. PubMed ID: 18499371
[TBL] [Abstract][Full Text] [Related]
28. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
29. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
Chen J; Qiu L; Hu M; Jin Y; Han J
Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908
[TBL] [Abstract][Full Text] [Related]
31. Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation.
Li J; Liu P; Liu JP; Zhang WL; Yang JK; Fan YQ
Eur J Pharm Biopharm; 2012 Feb; 80(2):426-32. PubMed ID: 22119664
[TBL] [Abstract][Full Text] [Related]
32. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
Chella N; Tadikonda R
Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.
Van den Mooter G; Weuts I; De Ridder T; Blaton N
Int J Pharm; 2006 Jun; 316(1-2):1-6. PubMed ID: 16563676
[TBL] [Abstract][Full Text] [Related]
34. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000.
Dang YJ; Hu CH; An LN; Zhu CY
Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):157-62. PubMed ID: 20448857
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
Feng J; Xu L; Gao R; Luo Y; Tang X
Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
[TBL] [Abstract][Full Text] [Related]
36. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
[TBL] [Abstract][Full Text] [Related]
37. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
Sammour OA; Hammad MA; Megrab NA; Zidan AS
AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
[TBL] [Abstract][Full Text] [Related]
38. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.
Sancheti PP; Karekar P; Vyas VM; Shah M; Pore YV
Pharmazie; 2009 Apr; 64(4):227-31. PubMed ID: 19435139
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
Passerini N; Albertini B; Perissutti B; Rodriguez L
Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
[TBL] [Abstract][Full Text] [Related]
40. Development and physicochemical evaluation of pharmacosomes of diclofenac.
Semalty A; Semalty M; Singh D; Rawat MS
Acta Pharm; 2009 Sep; 59(3):335-44. PubMed ID: 19819829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
